Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content
Fig. 4 | BMC Cancer

Fig. 4

From: Comprehensive analysis of metabolism-related gene biomarkers reveals their impact on the diagnosis and prognosis of triple-negative breast cancer

Fig. 4

Validation of metabolism-related prognostic signatures in TNBC using two independent cohorts. (A) Distribution of patient survival status and survival time according to the risk score in the GSE58812 dataset. (B) Expression heatmap of five key genes in the low- and high-risk groups within the GSE58812 dataset. (C) Kaplan‒Meier survival curves for the low- and high-risk groups derived from the GSE58812 dataset. (D) Time-dependent ROC analysis of the 2-, 4-, and 6-year overall survival (OS) probabilities in the GSE58812 dataset. (E) Distribution of patient survival status and survival time according to the risk score in the GSE21653 dataset. (F) Expression heatmap of five key genes in the low- and high-risk groups within the GSE21653 dataset. (G) Kaplan-Meier survival curves for the low- and high-risk groups derived from the GSE21653 dataset. (H) Time-dependent ROC analysis of the 2-, 4-, and 6-year overall survival (OS) probabilities in the GSE21653 dataset

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us